<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01979887</url>
  </required_header>
  <id_info>
    <org_study_id>195263-007</org_study_id>
    <nct_id>NCT01979887</nct_id>
  </id_info>
  <brief_title>Characterization of Signs and Symptoms of Participants With and Without Meibomian Gland Dysfunction</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Allergan</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Allergan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an exploratory study to evaluate endpoints used to characterize participants with and
      without meibomian gland dysfunction (MGD) and will evaluate the correlation between signs and
      symptoms of MGD. No investigational drug will be administered in this study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Meibum Quality Score in the Study Eye as Assessed by the Investigator Using a 4-Point Scale</measure>
    <time_frame>Day 22</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">75</enrollment>
  <condition>Meibomian Glands</condition>
  <arm_group>
    <arm_group_label>Non-MGD Participants</arm_group_label>
    <description>Participants without MGD who have meibum expressed as per protocol. No investigational drug is administered in this study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mild-Moderate MGD Participants</arm_group_label>
    <description>Participants with Mild-Moderate MGD who have meibum expressed as per protocol. No investigational drug is administered in this study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Severe MGD Participants</arm_group_label>
    <description>Participants with Severe MGD who have meibum expressed as per protocol. No investigational drug is administered in this study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Meibum Expression</intervention_name>
    <description>Meibum expression as per protocol. No investigational drug is administered in this study.</description>
    <arm_group_label>Non-MGD Participants</arm_group_label>
    <arm_group_label>Mild-Moderate MGD Participants</arm_group_label>
    <arm_group_label>Severe MGD Participants</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Tears
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants characterized as with or without Meibomian Gland Dysfunction.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -Participants characterized as with or without Meibomian Gland Dysfunction.

        Exclusion Criteria:

          -  Lid heating therapy, therapeutic gland expression, or meibomian gland probing within
             12 months of enrollment

          -  Contact lens use in the 30 days prior to enrollment

          -  Lid hygiene within 48 hours prior to enrollment

          -  Use of eye makeup within 8 hours of enrollment

          -  Eyelash growth-stimulating products within 30 days prior to enrollment

          -  Use of systemic vitamins and/or systemic supplements containing omega 3 fatty acids
             within 60 days of enrollment

          -  Use of systemic anti-histamines within 30 days prior to enrollment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Allergan</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 4, 2013</study_first_submitted>
  <study_first_submitted_qc>November 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 8, 2013</study_first_posted>
  <last_update_submitted>August 14, 2014</last_update_submitted>
  <last_update_submitted_qc>August 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

